About Aditi Ganguly
Aditi is an experienced content developer and financial writer who is passionate about helping investors understand the do's and don'ts of investing. She has a keen interest in the stock market and has a fundamental approach when analyzing equities.
Aditi's fascination with the stock market began in college, where she majored in Economics, while researching The Great Recession for her thesis. After graduating, she began her career handling the content requirements for the mutual fund aggregator Groww. Since then she has become a financial journalist that focuses on writing articles that educate retail investors about the equity markets and the global economy.
Recent Articles By Aditi Ganguly
Is Thermo Fisher Scientific a Good Healthcare Stock to Invest in?
The healthcare industry in developed countries is shifting its focus to other therapy areas and restructuring its operations as COVID-19 infection curves flatten with mass vaccination drives. Given this, we think medical equipment manufacturer Thermo Fisher Scientific (TMO) should witness a substantial rise in its financials and stock price soon. Read on.
2 Pharmaceutical Stocks Cathie Wood Loves
The booming pharmaceutical industry is showing no signs of slowing down. As the COVID-19 pandemic shows increasing signs of retreat in developed countries, major pharmaceutical companies are now turning their attention to the development of drugs for the treatment of other serious diseases. Cathie Wood is betting on DNA sequencing as the next big thing in the healthcare industry and has substantial investments in Novartis AG (NVS) and Bristol-Myers Squibb Company (BMY). So, let’s look closer at these names.
3 Speculative Stocks Cathie Wood Recently Bought
Cathie Wood’s strategy is to build positions in relatively new and speculative companies that are still in their developmental stages. These companies typically take some time to deliver returns and, hence, are deemed risky investment bets for the short term. Three such recent investments by Woods are in Beam Therapeutics (BEAM), Niu Technologies (NIU) and Workhorse Group (WKHS). Let’s evaluate these names.
Is Adobe Still a Good Software Stock to Buy?
As one of the largest software and cloud computing companies in the world, Adobe (ADBE) reported solid growth in its financials over the past year, driven by pandemic tailwinds. However, as the tech industry slows as a faster-than-anticipated macroeconomic recovery kicks in, will ADBE be able to retain its growth trajectory? Read more to find out.
2 Blockchain ETFs to Consider Buying in Q2
Blockchain technology applications go well beyond cryptocurrency. With the potential to disrupt capital markets, cloud computing and the clean energy industry, blockchain is expected to lead technological innovations in the coming months. Consequently, blockchain ETFs Siren Nasdaq NexGen Economy (BLCN) and First Trust Indxx Innovative Transaction & Process (LEGR) are expected to deliver solid returns this year. So, let’s take a closer look at these funds.
4 Reddit Stocks to Avoid Like the Plague
Following the GameStop short-squeeze last year, the Reddit forum r/WallStreetBets (WSB) has grown immensely popular. Investors on Reddit’s chat room focus mainly on speculative penny stocks that possess high short interest because of their poor financials and bleak growth potential. While WSB’s huge bets against short sellers and consequent short squeezes can help these stocks skyrocket in price, they are tremendously risky investment bets. So, we think Reddit stocks Sundial Growers (SNDL), Ocugen (OCGN), Castor Maritime (CTRM), and Naked Brand Group (NAKD), which have bleak growth outlooks, are best avoided now. Let’s discuss these names in more detail.
Is Goldman Sachs Stock a Smart Investment?
The world’s second-largest investment banking firm, Goldman Sachs (GS), exhibited nimble business execution amid the recent Archegos sell-off and delivered record profits in the first quarter. However, given President Biden’s plans to hike capital gains taxes along with corporate taxes, will GS be able to maintain its stellar performance? Read more to find out.
3 Cathie Wood Healthcare Stocks to Add to Your Portfolio
Despite generating lean capital gains on her holdings in the healthcare industry, Cathie Wood has maintained her positions because she expects genomics to emerge as the next big sector in 2021 that could deliver electric vehicle (EV) industry-like gains. As such, with their progress in the field of therapeutics and cancer research, Novartis (NVS), Vertex Pharmaceuticals (VRTX), and Regeneron Pharmaceuticals (REGN) are the top holdings in Wood’s Genomic Revolution (ETF). Thus, we think these companies should be valuable additions to one’s portfolio.
Is Recent IPO UTime a Good Buy?
Chinese electronics manufacturer United Time Technology’s (UTME) stellar market debut took investors by storm as the stock witnessed quadruple gains. However, does the company’s financials and growth potential support such price gains amid an ongoing tech sell-off? Read more to find out.